The pharmaceutical giant Pfizer said on Monday that it had struck a $160 billion deal, including debt, to merge with Allergan, the maker of Botox, in one of the biggest takeovers in the health care industry.
Source: Pfizer to Merge With Allergan in $160 Billion Deal – The New York Times